Matthew Burriesci was appointed as the new director of development for the National Association of Chain Drug Stores (NACDS) Foundation on August 20.
Matthew Burriesci was appointed as the new director of development for the National Association of Chain Drug Stores on August 20.
Burriesci was previously the executive director of PEN/Faulkner Foundation in Washington, DC. In his new position, he will contribute to the culture and philanthropy of NACDS Foundation by improving its efforts to advance public health, according to a press release.
"The NACDS Foundation has a bold vision that requires a talented team," said NACDS Foundation President Kathleen Jaeger in the release.
Burriesci will report directly to Jaeger and will be responsible for building and maintaining relationships with new and existing donors and Foundation supporters.
"Matt brings all of the right qualifications to marshal support for NACDS Foundation programs that seek nothing less than to improve public health," Jaeger said.
Burriesci will also work on fundraising strategies for evidence-based research, charitable advancement, and education programs.
In the past, Burriesci worked for the Association of Writers & Writing Programs, the Association of Academic Health Centers, and the Chicago Shakespeare Theater.
"We are excited to welcome him and look forward to his work with the NACDS Foundation Board and with the Foundation’s amazing donors," Jaeger said.
Unlock the Benefits of Centralized Fulfillment for Pharmacists: A Comprehensive Guide
November 6th 2024Streamline your pharmacy operations with centralized fulfillment. Discover how automation and advanced software can improve patient care, reduce operational errors, and create a better work environment for pharmacists. Download our whitepaper to learn how centralized fulfillment can address rising prescription volumes and staffing shortages. Request a consultation today to explore the best solution for your pharmacy.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.